Archive | Health Professionals

The ongoing racial disparities in melanoma: an analysis of the Surveillance, Epidemiology, and End Results database (SEER) database (1975-2016)

Although the majority of cutaneous melanoma patients are non-Hispanic white (NHW), minorities consistently suffer worse melanoma specific survival (MSS). Much of the literature comes from analyses of registries from the 1990s and 2000s.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Scientists identify key driver in BRAF inhibitor resistant melanoma

Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Moffitt researchers identify metastasis driver in BRAF inhibitor resistant melanoma

TAMPA, Fla. — Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Dr. Blank on the OpACIN, OpACIN-neo Trials in Stage III Macroscopic Melanoma

Christian U. Blank, MD, PhD, a medical oncologist in the Division of Immunology at the Netherlands Cancer Institute, discusses the OpACIN and OPACIN-neo trials examining ipilimumab (Yervoy) plus nivolumab (Opdivo) in stage III macroscopic melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports